Physiology of Activins/Follistatins: Associations With Metabolic and Anthropometric Variables and Response to Exercise
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Context: Clinical trials are evaluating the efficacy of inhibitors of the myostatin pathway in neuromuscular and metabolic diseases. Activins and follistatins are major regulators of the myostatin pathway, but their physiology in relation to metabolic and anthropometric variables and in response to exercise remains to be fully elucidated in humans. Objective: We investigated whether concentrations of circulating activin A, activin B, follistatin, and follistatin-like 3 (FSTL3) are associated with anthropometric and metabolic variables and whether they are affected by exercise. Design: Activin A, activin B, follistatin, and FSTL3 were measured in (1) 80 subjects divided according to age (young vs old) and fitness status (active vs sedentary) before and after exercise at 70% maximal oxygen consumption (VO2max), followed by 90% of VO2max until exhaustion; and (2) 23 subjects [9 healthy and 14 with metabolic syndrome (MetS)] who completed four sessions: no exercise, high-intensity interval exercise, continuous moderate-intensity exercise, and resistance exercise for up to 45 minutes. Results: At baseline, follistatin and FSTL3 concentrations were positively associated with age, fat percentage, and body mass index (P < 0.001). Follistatin was positively associated with serum cholesterol (P = 0.005), low-density lipoprotein cholesterol (P = 0.01), triglycerides (P = 0.033), and blood pressure (P = 0.019), whereas activin A and activin B were higher in physically active participants (P = 0.056 and 0.029, respectively). All exercise types increased the levels of all hormones ∼10% to 21% (P = 0.034 for activin B, P < 0.001 for the others) independent of the presence of MetS. Conclusion: Concentrations of circulating activins and follistatins are associated with metabolic parameters and increase after 45 minutes of exercise.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Follistatin originates from the liver and rises when the glucagon-to-insulin ratio increases in the case of fasting and aerobic and resistance exercise [74].”
From Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions (2021) · cites this paper as [74]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In humans, circulating follistatin is primarily derived from the liver and, similar to FGF21 and ANGPTL4, increases in response to an augmented glucagon-to-insulin ratio in conditions such as fasting and exercise, including HIIT, continuous aerobic, and resistance modalities [182,198].”
From The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review (2020) · cites this paper as [182]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration.
Dill, D. B., & Costill, D. L. (1974) · Journal of Applied Physiology · doi:10.1152/jappl.1974.37.2.247 · Cited by 3,384
Muscles, exercise and obesity: skeletal muscle as a secretory organ
Pedersen, B. K., & Febbraio, M. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.49 · Cited by 2,909
Muscle wasting in disease: molecular mechanisms and promising therapies
Cohen, S., Nathan, J. A., & Goldberg, A. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4467 · Cited by 1,089
A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy
Wagner, K. R., Fleckenstein, J. L., Amato, A. A., Barohn, R. J., Bushby, K., Escolar, D. M., Flanigan, K. M., Pestronk, A., Tawil, R., Wolfe, G. I., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21338 · Cited by 481
Strength Training with Blood Flow Restriction Diminishes Myostatin Gene Expression
LAURENTINO, G. C., UGRINOWITSCH, C., ROSCHEL, H., AOKI, M. S., SOARES, A. G., NEVES, M., AIHARA, A. Y., DA ROCHA CORREA FERNANDES, A., & TRICOLI, V. (2012) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318233b4bc · Cited by 464
Huh, J. Y., Mougios, V., Kabasakalis, A., Fatouros, I., Siopi, A., Douroudos, I. I., Filippaios, A., Panagiotou, G., Park, K. H., & Mantzoros, C. S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1437 · Cited by 363
Self-citationExercise-induced myokines and their role in chronic diseases
Pedersen, B. K. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.02.010 · Cited by 362
Myostatin/activin pathway antagonism: molecular basis and therapeutic potential
Han, H. Q., Zhou, X., Mitch, W. E., & Goldberg, A. L. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.05.019 · Cited by 314
Campbell, C., McMillan, H. J., Mah, J. K., Tarnopolsky, M., Selby, K., McClure, T., Wilson, D. M., Sherman, M. L., Escolar, D., & Attie, K. M. (2017) · Muscle & Nerve · doi:10.1002/mus.25268 · Cited by 240
Inhibin at 90: From Discovery to Clinical Application, a Historical Review
Makanji, Y., Zhu, J., Mishra, R., Holmquist, C., Wong, W. P. S., Schwartz, N. B., Mayo, K. E., & Woodruff, T. K. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1003 · Cited by 186
Assessing the role of muscle protein breakdown in response to nutrition and exercise in humans.
Tipton, K. D., Hamilton, D. L., & Gallagher, I. J. (2018) · Sports Medicine · doi:10.1007/s40279-017-0845-5 · Cited by 152
Mariot, V., Joubert, R., Hourdé, C., Féasson, L., Hanna, M., Muntoni, F., Maisonobe, T., Servais, L., Bogni, C., Le Panse, R., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01486-4 · Cited by 136
Circulating follistatin is liver-derived and regulated by the glucagon-to-insulin ratio
Hansen, J. S., Rutti, S., Arous, C., Clemmesen, J. O., Secher, N. H., Drescher, A., Gonelle-Gispert, C., Halban, P. A., Pedersen, B. K., Weigert, C., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3668 · Cited by 125
Hansen, J. S., Pedersen, B. K., Xu, G., Lehmann, R., Weigert, C., & Plomgaard, P. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1681 · Cited by 106
Bimagrumab improves body composition and insulin sensitivity in insulin‐resistant individuals
Garito, T., Roubenoff, R., Hompesch, M., Morrow, L., Gomez, K., Rooks, D., Meyers, C., Buchsbaum, M. S., Neelakantham, S., Swan, T., et al. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13042 · Cited by 88
A complex role of activin A in non-alcoholic fatty liver disease
Yndestad, A., Haukeland, J. W., Dahl, T. B., Bjøro, K., Gladhaug, I. P., Berge, C., Damås, J. K., Haaland, T., Løberg, E. M., Linnestad, P., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.318 · Cited by 75
Fatouros, I. G., Jamurtas, A. Z., Nikolaidis, M. G., Destouni, A., Michailidis, Y., Vrettou, C., DOUROUDOS, I. I., Avloniti, A. A., Chatzinikolaou, A., Taxildaris, K., et al. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.08.020 · Cited by 72
Self-citationActivins in adipogenesis and obesity
Dani, C. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.28 · Cited by 67
What do we know about the cardiac benefits of exercise?
Wei, X., Liu, X., & Rosenzweig, A. (2015) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.12.014 · Cited by 59
Treating cancer cachexia to treat cancer
Lee, S.-J., & Glass, D. J. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-2 · Cited by 50
Perakakis, N., Upadhyay, J., Ghaly, W., Chen, J., Chrysafi, P., Anastasilakis, A. D., & Mantzoros, C. S. (2018) · Metabolism · doi:10.1016/j.metabol.2018.05.003 · Cited by 48
Self-citationDalbo, V. J., Roberts, M. D., Sunderland, K. L., Poole, C. N., Stout, J. R., Beck, T. W., Bemben, M., & Kerksick, C. M. (2011) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glr091 · Cited by 47
Changes in Serum Levels of Myokines and Wnt-Antagonists after an Ultramarathon Race
Kerschan-Schindl, K., Thalmann, M. M., Weiss, E., Tsironi, M., Föger-Samwald, U., Meinhart, J., Skenderi, K., & Pietschmann, P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132478 · Cited by 46
Elliott, B. T., Herbert, P., Sculthorpe, N., Grace, F. M., Stratton, D., & Hayes, L. D. (2017) · Physiological Reports · doi:10.14814/phy2.13343 · Cited by 43
The Relationship between Exercise, Nutrition and Type 2 Diabetes
Stephenson, E. J., Smiles, W., & Hawley, J. A. (2014) · Medicine and Sport Science · doi:10.1159/000357331 · Cited by 39
Exercise Does Not Influence Myostatin and Follistatin Messenger RNA Expression in Young Women
Jensky, N. E., Sims, J. K., Dieli-Conwright, C. M., Sattler, F. R., Rice, J. C., & Schroeder, E. T. (2010) · Journal of Strength and Conditioning Research · doi:10.1519/jsc.0b013e3181c8664f · Cited by 37
Activin A and follistatin in patients with nonalcoholic fatty liver disease
Polyzos, S. A., Kountouras, J., Anastasilakis, A. D., Triantafyllou, G. Α., & Mantzoros, C. S. (2016) · Metabolism · doi:10.1016/j.metabol.2016.07.009 · Cited by 36
Self-citationSiopi, A., Deda, O., Manou, V., Kellis, S., Kosmidis, I., Komninou, D., Raikos, Ν., Christoulas, K. I., Theodoridis, G. A., & Mougios, V. (2017) · Metabolites · doi:10.3390/metabo7010005 · Cited by 36
Self-citationPopov, D. V., Lysenko, E. A., Bachinin, A. V., Miller, T. F., Kurochkina, N. S., Kravchenko, I. V., Furalyov, V. A., & Vinogradova, O. L. (2015) · Muscle & Nerve · doi:10.1002/mus.24314 · Cited by 32
Schwarz, N. A., McKinley-Barnard, S. K., Spillane, M., André, T., Gann, J. J., & Willoughby, D. S. (2016) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2016-0047 · Cited by 29
Zisi, C., Sampsonidis, I., Fasoula, S., Papachristos, K., Witting, M. A., Gika, H., Nikitas, P., & Pappa-Louisi, A. (2017) · Metabolites · doi:10.3390/metabo7010007 · Cited by 28
Anastasilakis, A. D., Pοlyzos, S. A., Skouvaklidou, E. C., Kynigopoulos, G., Saridakis, Z. G., Apostolou, A., Triantafyllou, G. A., Karagiozoglou‐Lampoudi, Τ., & Mantzoros, C. S. (2016) · Metabolism · doi:10.1016/j.metabol.2016.07.002 · Cited by 26
Self-citationHan, D., Hsiao, M., Wang, T., Chen, S., & Yang, W. (2016) · BMC Neurology · doi:10.1186/s12883-016-0661-9 · Cited by 24
Increased serum activin‐A differentiates alcoholic from cirrhosis of other aetiologies
Voumvouraki, A., Notas, G., Koulentaki, M., Γεωργιάδου, Μ., Klironomos, S., & Kouroumalis, E. (2012) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2012.02647.x · Cited by 20
MSTN mRNA After Varying Exercise Modalities in Humans
Schiffer, T., Geisler, S., Sperlich, B., & Strüder, H. K. (2011) · International Journal of Sports Medicine · doi:10.1055/s-0031-1279732 · Cited by 15
Cited by
Gonzalez-Gil, A. M., & Elizondo-Montemayor, L. (2020) · Nutrients · doi:10.3390/nu12061899 · Cited by 278
Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions
de Oliveira dos Santos, A. R., de Oliveira Zanuso, B., Miola, V. F. B., Barbalho, S. M., Santos Bueno, P. C., Flato, U. A. P., Detregiachi, C. R. P., Buchaim, D. V., Buchaim, R. L., Tofano, R. J., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052639 · Cited by 189
Perakakis, N., Stefanakis, K., & Mantzoros, C. S. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154320 · Cited by 162
Self-citationStefanakis, K., Kokkorakis, M., & Mantzoros, C. S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156057 · Cited by 142
Self-citationEmerging pharmacotherapies for obesity: A systematic review
Kokkorakis, M., Chakhtoura, M., Rhayem, C., Al Rifai, J., Ghezzawi, M., Valenzuela-Vallejo, L., & Mantzoros, C. S. (2025) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001045 · Cited by 102
Self-citation
Metadata
- Authors
- Perakakis, N., Mougios, V., Fatouros, I., Siopi, A., Draganidis, D., Peradze, N., Ghaly, W., & Mantzoros, C. S.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Aristotle University of Thessaloniki (GR)
- University of Thessaly (GR)
- Corresponding author
- Mantzoros, Christos S
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2018-08-01
- Volume
- 103
- Issue
- 10
- Pages
- 3890-3899
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC6179167
- OpenAlex
- W2885628972
- Cited by
- 52
- References
- 35
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 9 · 2023: 9 · 2022: 2 · 2021: 7 · 2020: 9 · 2019: 5 · 2018: 2
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
- Funders
- National Institutes of Health (K24D081913)
- Deutsche Forschungsgemeinschaft (389891681)
- State Scholarships Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Exercise and Physiological Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Physical Performance
- Keywords
- activin A, activin B, follistatin, FSTL3, exercise response, metabolic syndrome, anthropometric variables, serum lipids, blood pressure, resistance training, high-intensity interval exercise, physical activity
- MeSH terms
- Adolescent, Adult, Aged, Aging, Anthropometry, Body Composition, Humans, Male, Middle Aged, Physical Fitness, Exercise, Activins, Follistatin, Follistatin-Related Proteins, Adiposity, Young Adult, Sedentary Behavior
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.